12 Week Rosacea Trial
added 2/14/12
Augusta Centre for Dermatology
18 yrs. or older, must have acne type bumps to qualify
Contacts:
Principal Investigator
Anne M. Loebl,
MD
annemloebl@comcast.net
Research Coordinator
Pam Boulineau
Phase 3
Hidradenitis Study
added 2/8/12
The
study is double blind placebo controlled for the first year, randomized to
either weekly Humira or placebo for the first 12 weeks. Must have
trial of 3 months of continuous oral antibiotics. After that year,
patients are eligible for a 5 year open label extension study, i.e. 5
years of free Humira if they are responders. I did the phase 2 study with
great results.
Contacts:
Principal Investigator
Jamie Weisman, MD
jweisman@peachtreedermatology.com
Research coordinator
Ann Marie Edwards
research@peachtreedermatology.com
Moderate to severe
psoriasis
added 2/8/12
Requirements BSA 10% or
more, PASI of 12.
Contacts:
Principal Investigator
Jamie Weisman, MD
jweisman@peachtreedermatology.com
Research coordinator
Ann Marie Edwards
research@peachtreedermatology.com
Cutaneous lupus trial
added 2/8/12
Discoid or SCLE. Cannot
have renal disease. Same contacts.
Contacts:
Principal Investigator
Jamie Weisman, MD
jweisman@peachtreedermatology.com
Research coordinator
Ann Marie Edwards
research@peachtreedermatology.com
Suephy Chen
schen2@emory.edu
Pediatric Urticaria
Pigmentosa (UP) Registry added 4/26/11
Objectives:
Observational study to collect long term data on the natural history of
UP, including timing to resolution, factors predicting progression,
associated symptoms, and markers of severity.
Participants will receive
a questionnaire/interview and physical exam every 1-2 years so that the
extent and activity of their disease can be tracked. Findings will be
entered into a database registry. In those with active UP, laboratory
testing requiring a small amount of blood may be needed. Risks of the
study are minimal. The study has been approved by the Emory Institutional
Review Board.
Study Population:
Patients with urticaria pigmentosa diagnosed at an age of < 15 and within
the past 25 years.
Exclusion criteria:
-
Inability to speak
or read English
-
Diffuse cutaneous
mast cell disease
-
TMEP
-
> 15 years of age
when diagnosed with UP
-
fewer than 5
mastocytomas
|
